Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood marker may forecast recovery after colon surgery

NCT ID NCT02395380

Knowledge-focused Sponsor: Centre Hospitalier Departemental Vendee Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether measuring C-reactive protein (CRP) in the blood after colorectal surgery can help predict how well a patient will recover. Researchers followed 174 adults who had planned colon surgery. They checked CRP levels on the third day after surgery and compared them to recovery signs like fever, pain, bowel function, and mobility on the fifth day. The goal was to see if CRP could be a useful tool for doctors to plan patient care and hospital stays.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

174 people

The number who actually took part.

Started

Jul 2015

Finished

Jun 2017

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Upper age to 18 years * Planned hospital stay for a colonic resection with anastomosis without permanent or temporary digestive bypass * Patient with pre-operative CRP lower or egal to 172 mg/L * No opposition at the participation of the study * Expected patient return home after surgery (or convalescent home or not medicalized institution) Exclusion Criteria: * Patient under guardianship * Protected or private patient freedom * Minor patient * Colectomy surgery with digestive bypass or digestive anastomosis * Complex combined surgery (significantly intestinal resection associated, another surgical procedure that can interfere with postoperative CRP) * General inflammatory disease susceptive to modify dosage values * Anti-inflammatory therapy (AINS/ corticosteroids/ immunosuppressive) * Patient unable to understand the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Colorectal postoperative complication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Colorectal postoperative complication

Contacts and locations

Locations

  • CHU Nantes

    Nantes, 44000, France

  • Centre Hospitalier Departemental Vendee

    La Roche-sur-Yon, 85925, France